Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN RAMON, Calif., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
-
CAMBRIDGE, Mass., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies coupled to patient enrichment,...
-
PORTLAND, OR--(Marketwired - Jan 20, 2016) - Puppet Labs, the leading provider of IT automation software, is starting the year with three announcements to fuel continued growth in 2016 and beyond....
-
Dublin, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/4qbq3q/in_vitro) has announced the addition of the "In Vitro Diagnostic...
-
Dublin, Jan. 18, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/53xptt/world_market_for) has announced the addition of the "World Market for...
-
SAN FRANCISCO, Jan. 15, 2016 (GLOBE NEWSWIRE) -- The Independent Selection Panel of the Bay Area CFO of the Year Awards announced today Peter Oppenheimer, former Senior Vice President and CFO, Apple...
-
SEATTLE, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY), a clinical-stage biopharmaceutical company dedicated to the development of therapeutic products that can improve the...
-
BURNABY, British Columbia, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today outlined its anticipated key corporate...
-
Dublin, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/f7m9sb/antibody_drug) has announced the addition of the "Antibody Drug...
-
SEATTLE and SOUTH SAN FRANCISCO, Calif., Jan. 08, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today announced that the U.S....